Vertex Pharmaceuticals (VRTX) Cost of Revenue (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Cost of Revenue of $489.2 million for Q2 2026, up 24.54% on a QoQ basis from $392.8 million in Q1 2026, and up 20.05% year-over-year from $407.5 million in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Cost of Revenue (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Cost of Revenue for 18 years, with the latest figure at $489.2 million in Q2 2026.
- On a quarterly basis, Cost of Revenue rose 20.05% year-over-year to $489.2 million in Q2 2026; TTM through Jun 2026 was $1.8 billion, a 11.11% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 7.89% from the prior year.
- Cost of Revenue was $489.2 million for Q2 2026 at Vertex Pharmaceuticals, up from $392.8 million in the prior quarter.
- The five-year high for Cost of Revenue was $489.2 million in Q2 2026, with the low at $245.8 million in Q1 2022.
- Average Cost of Revenue over 5 years is $355.9 million, with a median of $365.5 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Cost of Revenue rose 29.9% in 2023, then climbed 5.65% in 2025.
- Over 5 years, Cost of Revenue stood at $283.3 million in 2022, then grew by 29.9% to $368.0 million in 2023, then increased by 15.05% to $423.4 million in 2024, then advanced by 10.06% to $466.0 million in 2025, then increased by 4.98% to $489.2 million in 2026.
- The last three Cost of Revenue figures came in at $489.2 million (Q2 2026), $392.8 million (Q1 2026), and $466.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 8.05 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 4.29 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 4.40 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 3.71 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 2.52 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 2.81 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 1.58 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 4.09 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 489.20 Mn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 3.73 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 489.20 Mn |
| Mar 31, 2026 | 392.80 Mn |
| Dec 31, 2025 | 466.00 Mn |
| Sep 30, 2025 | 414.80 Mn |
| Jun 30, 2025 | 407.50 Mn |
| Mar 31, 2025 | 363.00 Mn |
| Dec 31, 2024 | 423.40 Mn |
| Sep 30, 2024 | 392.60 Mn |
| Jun 30, 2024 | 371.90 Mn |
| Mar 31, 2024 | 342.60 Mn |
| Dec 31, 2023 | 368.00 Mn |
| Sep 30, 2023 | 318.70 Mn |
| Jun 30, 2023 | 308.60 Mn |
| Mar 31, 2023 | 266.90 Mn |
| Dec 31, 2022 | 283.30 Mn |
| Sep 30, 2022 | 289.40 Mn |
| Jun 30, 2022 | 261.80 Mn |
| Mar 31, 2022 | 245.80 Mn |
| Dec 31, 2021 | 247.40 Mn |
| Sep 30, 2021 | 236.50 Mn |
API Access
Vertex Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();